Today: 19 June 2026

Nvidia’s Earnings Could Make or Break the AI Stock Trade

Nvidia’s Earnings Could Make or Break the AI Stock Trade

Nvidia rose 0.8% ahead of its earnings report, while CoreWeave dropped 3.7% after Google and Blackstone announced a $5 billion U.S. AI cloud venture using Google’s custom TPUs. The new venture will offer 500 megawatts of data-center capacity by 2027. AMD and Micron also gained, but Microsoft and Broadcom slipped. Investors are watching whether Nvidia can maintain dominance as competition in AI inference intensifies.
Celestica Drops in Toronto as AI Hardware Trade Struggles

Celestica Drops in Toronto as AI Hardware Trade Struggles

Celestica’s Toronto-listed shares fell about 5% Tuesday as the TSX reopened after Victoria Day, mirroring a 4.4% drop in its U.S.-listed shares Monday. The stock has retreated despite Celestica raising its 2026 revenue and profit outlook last month. Shares traded near $340.54 in New York early Tuesday afternoon. Other contract manufacturers, including Jabil and Flex, also declined.
19 May 2026
Chewy Slides After Consumer Warning

Chewy Slides After Consumer Warning

Chewy shares fell 7.8% to $19.95 in midday trading Tuesday after CEO Sumit Singh warned of increased consumer spending pressure at a JPMorgan conference. Trading volume topped 10.3 million shares. The drop outpaced declines in the S&P 500 and Nasdaq. Chewy reports fiscal first-quarter results before markets open June 10.
19 May 2026
Kroger Shares Trade as Investors Watch Price Cuts

Kroger Shares Trade as Investors Watch Price Cuts

Kroger shares rose 3.8% to $70.89 in midday trading Tuesday, outpacing gains in Walmart and Costco as Amazon fell. The move extends Monday’s rally, with investors reacting to new CEO Greg Foran’s focus on pricing and store execution. No new earnings were released. Volume reached about 3.54 million shares.
19 May 2026
Co-Diagnostics Stock Surges on Ebola Assay News — The Fine Print Is Big

Co-Diagnostics Stock Surges on Ebola Assay News — The Fine Print Is Big

Co-Diagnostics shares surged 51% Tuesday after the company announced completion of an assay strategy for the Bundibugyo Ebola virus, though the test is not yet for sale and awaits regulatory approval. Trading volume topped 94 million shares. The company reported $8.23 million in cash at March 31 and a quarterly net loss of $9.14 million, raising concerns about its financial stability.
Constellation Software Stock Climbs as Broader Canadian Market Loses Ground

Constellation Software Stock Climbs as Broader Canadian Market Loses Ground

Constellation Software shares surged 9.5% to C$2,860.21 in Toronto trading Tuesday after reopening from the Victoria Day holiday. The company reported Q1 revenue of $3.18 billion, up 20% from last year, and net income of $367 million. The S&P/TSX composite slipped 0.1% as inflation rose to 2.8% in April. Constellation completed $697 million in acquisitions during the quarter.
19 May 2026
InMed Soars 100% on $290M Migraine Deal

InMed Soars 100% on $290M Migraine Deal

InMed Pharmaceuticals shares jumped 108.6% to $1.42 after agreeing to merge with Mentari Therapeutics in an all-stock deal, shifting focus to migraine prevention. The combined company will operate as Mentari, backed by a $290 million private placement, with InMed shareholders owning about 1.51%. Nearly 69.6 million shares traded, and InMed’s market value reached $5.7 million.
19 May 2026
Dow Jones Falls as Bond Yields Signal Trouble for Bulls

Dow Jones Falls as Bond Yields Signal Trouble for Bulls

The Dow Jones Industrial Average dropped 249.36 points, or 0.5%, to 49,436.76 Tuesday morning as rising Treasury yields and oil prices pressured stocks. The 10-year Treasury yield hit 4.663%, its highest since January 2025. Brent crude stayed above $110 amid Middle East tensions. Home Depot reported first-quarter sales of $41.8 billion, up 4.8% from last year, and reaffirmed its 2026 outlook.
Whitecap Shares Touch 52-Week High as Buyers Stay In

Whitecap Shares Touch 52-Week High as Buyers Stay In

Whitecap Resources shares hit a 52-week high of CA$17.04 in Toronto on Tuesday, up 1.6% intraday, after confirming a May dividend and raising 2026 production guidance. The company reported record Q1 output of 391,416 boe/d and kept its capital budget steady. The S&P/TSX Composite opened higher as U.S.-Iran tensions eased, while crude prices slipped but stayed elevated. Whitecap’s market value stood at about CA$20.59 billion.
XRP’s $10 Bet Just Ran Into a $1.37 Problem

XRP’s $10 Bet Just Ran Into a $1.37 Problem

XRP traded near $1.37 Tuesday, down 1.1% over 24 hours, with a market value of $84.5 billion. Standard Chartered projected XRP could reach $2.80 in 2026, but analysts at The Motley Fool and TipRanks warned Ripple’s payments strategy may weaken XRP’s role. The U.S. Senate Banking Committee advanced the Clarity Act, but support remains uncertain. The SEC’s lawsuit against Ripple ended in 2025 with a $125 million fine.
19 May 2026
Nasdaq slips as Wall Street rally faces yield jolt

Nasdaq slips as Wall Street rally faces yield jolt

U.S. stocks fell Tuesday morning, with the Nasdaq down 1.05% and the S&P 500 off 0.69%, as rising Treasury yields and firm oil prices pressured markets. The U.S. 10-year yield neared 4.61%, while Brent crude traded at $110.67 a barrel. Materials and consumer discretionary sectors led declines. Investors await Nvidia’s earnings and Federal Reserve minutes due Wednesday.
Nebius Drops After Google, Blackstone Step Up 2026 AI Cloud Bet

Nebius Drops After Google, Blackstone Step Up 2026 AI Cloud Bet

Nebius Group N.V. shares dropped 7.5% to $184.84 in Nasdaq morning trading after Google and Blackstone announced a $5 billion U.S. AI cloud venture and D.A. Davidson downgraded the stock. CoreWeave, a peer, also fell 7.8%. Nebius reported Q1 revenue of $399 million, up 684% year-over-year, and raised its 2026 capital expenditure forecast to as much as $25 billion.
Generation Income Properties Up 46% After Heavy Volume

Generation Income Properties Up 46% After Heavy Volume

Generation Income Properties shares surged 45.5% to $0.3549 in early Nasdaq trading Tuesday, with volume above 105 million shares. The spike followed insider-ownership filings after a board shakeup, not new earnings or property sales. The company reported a $2.13 million quarterly loss and warned of “substantial doubt” about its ability to continue as a going concern. Nasdaq has given it until August 4 to meet equity requirements.
Snowflake Shares Jump Ahead of Results as Wall Street Bets on AI Demand

Snowflake Shares Jump Ahead of Results as Wall Street Bets on AI Demand

Snowflake shares rose 6.3% to $174.62 in morning trading Tuesday, outperforming major U.S. index funds. BofA Securities raised its price target to $205, citing strong demand for Snowflake’s AI tools. The company reports fiscal first-quarter results after the U.S. market close on May 27. Trading volume reached 3.6 million shares, with a market value near $59.4 billion.

Stock Market Today

  • uniQure Shares Surge 78% on FDA Support for AMT-130 Accelerated Approval
    June 19, 2026, 3:49 PM EDT. uniQure's stock jumped 78.4% after the FDA indicated that three-year phase I/II data for AMT-130, a gene therapy for Huntington's disease, could support a biologics license application (BLA) for accelerated approval. The FDA requested alignment on a confirmatory study design, favoring a control group over sham surgery, with plans expected before a 2026 Q3 BLA filing. This update follows earlier regulatory setbacks when the FDA questioned the sufficiency of phase I/II data compared to external controls. AMT-130 uses gene-silencing microRNA to target the huntingtin gene. The therapy is evaluated in ongoing phase I/II trials assessing safety and efficacy. uniQure aims to begin confirmatory studies promptly under FDA collaboration.

Latest articles

WELL Health slides as TSX holds steady; Circle Medical, cash flow draw attention

WELL Health slides as TSX holds steady; Circle Medical, cash flow draw attention

19 June 2026
WELL Health plunged 3.7% to C$4.19 in Toronto as investors looked past director election results and focused on falling Q1 operating adjusted free cash flow, which dropped to C$1.6 million from C$11.8 million a year earlier due to clinic investments, higher cash taxes, Circle Medical deferrals, and increased interest payments.
MDA Space stock rises as Blue Canyon deal targets U.S. defense market

MDA Space stock rises as Blue Canyon deal targets U.S. defense market

19 June 2026
MDA Space’s Toronto shares jumped 4.4% to C$58.08 after it agreed to buy Blue Canyon Technologies from RTX’s Raytheon for US$620 million cash, a move aimed at expanding access to U.S. defense-space work and classified programs; the deal is expected to add to adjusted EBITDA and EPS in 2027 but faces regulatory approval and integration risks.
Fermi rally stalls with Nasdaq closed for Juneteenth as proxy fight simmers

Fermi rally stalls with Nasdaq closed for Juneteenth as proxy fight simmers

19 June 2026
Fermi surged 10% to $9.50 before the Juneteenth market closure, fueled by speculation of a potential OpenAI-related customer for its Project Matador campus, but no binding tenant deal has been announced, leaving the rally exposed to profit-taking if a concrete agreement or joint venture isn’t revealed when trading resumes.
Go toTop